CAI 8-K 2026-09-14

Caris Life Sciences, Inc. (CAI) 8-K dated 2026-09-14 — accession 0002019410-26-000061. This URL is the filing, not the CAI hub.

Caris Life Sciences, Inc. (CAI) is a biotechnology company listed on NASDAQ.

Caris Life Sciences, Inc. filed a 8-K on 2026-09-14. Accession 0002019410-26-000061.

Cached items: 7.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.

Not investment advice. The CAI SEC hub lists recent forms. The stock page is the research view.